Developer docs
API playgroundTry for free, no card

Search company profiles

Prader‐Willi Syndrome Association | USA

Full company profile

uuid000gmb3

Namestring
Prader‐Willi Syndrome Association | USA
Legal namestring
Prader-Willi Syndrome Association | USA
Websiteurl
pwsausa.org
Company typeenum
Private
Founded yearint
1975
Descriptiontext

PWSA | USA is a 501(c)(3) nonprofit patient advocacy organization founded in 1975 and headquartered in Brandon, Florida, dedicated to supporting individuals affected by Prader-Willi Syndrome and their families. The organization operates as the de facto U.S. national advocacy body for PWS, a rare genetic condition affecting approximately 1 in 15,000 births. Its service portfolio spans direct family support (24/7 crisis line, parent mentoring, grief counseling, Package of Hope for newly diagnosed families), educational advocacy (WSEAT program, School Success Toolkit, IEP consulting), professional training (ECHO 4 PWS telementoring, Residential Providers Conference), and research coordination (Global PWS Registry, clinical trials information, brain tissue donation program, PWS Connect research initiative). Content and community channels include the PWS United podcast, segmented Facebook support groups by life stage and family role, the annual United in Hope National Convention, regional roadshows, and a biennial D.C. Fly-In advocacy event.

PWSA | USA generates revenue through individual donations, a tiered corporate sponsorship program (Diamond $300K, Platinum $200K, Gold $100K, Silver $50K) targeted at rare-disease pharmaceutical companies, planned giving and bequests, donor-advised funds, employer matching gifts, and a portfolio of fundraising events. Its go-to-market approach is community-led and event-driven, anchored by the annual national convention and supported by a national chapter network. The organization has no proprietary technology products; community platforms are built on third-party infrastructure (Trend Community for PWS Connect, Podbean for the podcast). Recent strategic activity includes the first joint International PWS Conference co-hosted with FPWR and IPWSO in June 2025, alignment with Soleno Therapeutics and subsequently Neurocrine Biosciences around the March 2025 FDA approval of VYKAT XR, and the 50th-anniversary Journey of Hope Gala in 2025.

Key leadership comprises CEO Stacy Ward, MS, BCBA, and founder Fausta Deterling. The organization is governed by a Board of Directors with input from a Special Education Advisory Board, CSAB Advisory Board, and Adults with PWS Advisory Board. Notable community advisors include Dr. Amy McTighe of Children's Institute of Pittsburgh. No parent company or private equity ownership exists; the organization operates autonomously as a 501(c)(3) public charity (Tax ID 41-1306908).

Short descriptiontext

Prader-Willi Syndrome Association | USA is a 501(c)(3) nonprofit founded in 1975 that provides 24/7 crisis support, family services, educational advocacy, professional training, and research coordination for individuals with Prader-Willi Syndrome and their families across the United States.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersBrandon, United States
HQ citystring
Brandon
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare disease advocacy, patient support services, family support programs, medical education resources, disability rights advocacy
NAICS code3 codes
  • Other Individual and Family Services624190
  • Individual and Family Services6241
  • Child and Youth Services624110
SIC code2 codes
  • Services-Social Services8300
  • Services-Misc Health & Allied Services, Nec8090
Product category
Rare Disease Patient Advocacy
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model6 records
1Individual Donations
TypeGrants Donations
Description

One-time and recurring donations from individuals, families, and supporters of the PWS community. Donations can be made online, by mail, or through social media platforms including Facebook fundraisers.

pwsausa.org
2Corporate Sponsorship
TypeOthers
Description

Tiered corporate sponsorship program with Diamond ($300,000), Platinum ($200,000), Gold ($100,000), Silver ($50,000) levels. Includes sponsor benefits for events, programs, and visibility.

pwsausa.org
3Planned Giving and Bequests
TypeOthers
Description

Legacy and planned giving programs including bequests, endowment funds, and tribute gifts. The organization offers sample bequest language for donors including unconditional, contingent, residue, and specific purpose bequests.

pwsausa.org
4Donor Advised Funds
TypeOthers
Description

Accepts grants from Donor Advised Funds (DAFs) as a distribution method for charitable giving.

pwsausa.org
5Fundraising Events
TypeOthers
Description

Various fundraising events including Move for PWS, Dancing Through the Decades, Cocktails for a Cause, Hummus & Watermelon brunches, golf tournaments, and seasonal campaigns.

pwsausa.org
6Matching Gifts
TypeOthers
Description

Corporate matching gift program where employers match employee donations, doubling the impact of individual contributions.

pwsausa.org
Marketing channels11 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details4 tiers
1Diamond Corporate Sponsor - $300,000
ModelOtherBilling cadenceMulti-year contract
Notes

Top-tier corporate sponsorship with maximum visibility and benefits at PWSA | USA events and programs.

pwsausa.org
2Platinum Corporate Sponsor - $200,000
ModelOtherBilling cadenceMulti-year contract
Notes

Second-tier corporate sponsorship with extensive visibility and program benefits.

pwsausa.org
3Gold Corporate Sponsor - $100,000
ModelOtherBilling cadenceMulti-year contract
Notes

Mid-tier corporate sponsorship with moderate visibility and benefits.

pwsausa.org
4Silver Corporate Sponsor - $50,000
ModelOtherBilling cadenceMulti-year contract
Notes

Entry-tier corporate sponsorship with basic visibility and benefits.

pwsausa.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

PWSA | USA is a 501(c)(3) nonprofit organization that delivers a comprehensive suite of support, education, advocacy, and research services for individuals affected by Prader-Willi Syndrome (PWS) and their families. Core offerings include a 24-hour crisis phone line, the Package of Hope for newly diagnosed families, parent mentoring, grief support, special education advocacy (WSEAT), the ECHO 4 PWS telementoring program, regional roadshows, the annual United in Hope National PWS Convention, the Global PWS Registry, and the PWS Connect Community & Research Initiative.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 24/7 crisis support available 365 days per year
+2 more records
Product overview1 text field

PWSA | USA offers a comprehensive suite of support services, educational resources, advocacy programs, and research initiatives for individuals and families affected by Prader-Willi Syndrome. The organization provides a 24-hour crisis support line, parent mentoring, grief support, and the Package of Hope for newly diagnosed families. Key programs include the ECHO 4 PWS healthcare education initiative, the annual United in Hope National Convention, the Residential Providers Conference, and the PWS Connect Community & Research Initiative. The organization also maintains educational resources including the Growth Hormone Booklet, PWS Fact Sheets, and the PWS United Podcast. Advocacy programs include the biennial D.C. Fly-In and the PWS Advocacy Master Class. Research support is provided through the Global PWS Registry, clinical trials information, and brain tissue donation program.

Product and service13 records
124-Hour Crisis Phone Line
CategoryCrisis Support Service
Description

24/7/365 crisis support line staffed by knowledgeable Family Support team members providing immediate expert support to families facing medical or behavioral emergencies.

2Package of Hope
CategoryNew Diagnosis Resource
Description

Comprehensive support package provided to newly diagnosed families containing educational literature, counseling resources, nutrition and medical information about Prader-Willi Syndrome.

3Family Support Services
CategoryFamily Support Service
Description

Comprehensive support services for individuals diagnosed with PWS, their families, and care providers, providing critical information and resources on PWS care, crisis counseling, and referrals.

4Parent Mentoring Program
CategoryPeer Support Program
Description

Program connecting veteran PWS parents with newly diagnosed families to provide support, referrals to physicians, best practices, and additional support benefits.

5Grief Support Services
CategoryBereavement Support Service
Description

Grief counseling and emotional support services for members of the PWS community who are grieving.

6ECHO 4 PWS
CategoryHealthcare Education Program
Description

Project ECHO-based telemedicine and education program designed to increase access to locally trained specialists and decrease healthcare disparity through rapid dissemination of best practices for PWS care.

7United in Hope National PWS Convention
CategoryCommunity Event
Description

Annual national convention bringing together individuals with PWS, families, and professionals for education, networking, and community connection.

8Residential Providers Conference
CategoryProfessional Training Event
Description

Annual conference for residential care providers serving individuals with Prader-Willi syndrome, offering training, best practices sharing, and networking opportunities.

9D.C. Fly-In Advocacy Event
CategoryAdvocacy Program
Description

Biennial advocacy event bringing PWS advocates to Washington D.C. to meet with elected officials and advance legislative priorities.

10PWS Advocacy Master Class
CategoryAdvocacy Training
Description

Six-week program designed in collaboration with Patients Rising providing a robust curriculum for becoming an effective PWS policy advocate.

11School Success Program
CategorySpecial Education Advocacy
Description

Program helping parents navigate educational systems, advocate for their child's rights and accommodations, and create effective learning environments for students with PWS.

12Provider Trainings
CategoryProfessional Training
Description

Training programs for healthcare providers, residential staff, and caregivers serving individuals with PWS.

13PWS Connect Community & Research Initiative
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-06
Description

Community update partner following acquisition of Soleno Therapeutics on April 6, 2026. Soleno developed VYKAT XR (diazoxide choline controlled-release), the first FDA-approved treatment for hyperphagia in PWS.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-06-24
Description

Co-host of the United in Hope International PWS Conference held June 24-28, 2025 at Arizona Grand Resort and Spa in Phoenix. First joint conference bringing together all three major PWS organizations for the largest international PWS conference ever held.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-06-24
Description

Co-host of the United in Hope International PWS Conference, partnering with PWSA | USA and FPWR to create the first joint international PWS conference, bringing together families, researchers, and professionals from around the world.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-26
Description

Longstanding community partner whose VYKAT XR treatment received FDA approval on March 26, 2025 - a historic milestone for the PWS community. PWSA | USA provides community updates and support for patients accessing this treatment.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Project ECHO program launched in May 2023 to increase access to specialized PWS care by training local providers. Uses telementoring to disseminate best practices to healthcare providers lacking PWS expertise.

Strategic tierCoreTypeOthersAnnounced on2021-01-01
Description

Platinum member of NORD, the leading rare disease advocacy organization in the United States. Provides access to resources, advocacy coordination, and peer support among rare disease organizations.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Partner organization supporting brain tissue donation for research. Helps facilitate post-mortem brain tissue donation from individuals with PWS to advance understanding of the condition.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Community update partner working on the HERO clinical trial for PWS treatment. PWSA | USA shares updates with the community about clinical trial developments and pauses.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Home to the Center for Prader-Willi Syndrome and PWS Program Manager Dr. Amy McTighe, who serves as Chair of PWSA | USA's Special Education Advisory Board.

10Prader-Willi Syndrome Association of Colorado
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

State chapter providing IEP consulting services and collaborating with the PWS multi-disciplinary clinic at Children's Hospital in Denver.

pwsausa.org
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Collaboration to develop the PWS Advocacy Master Class - a six-week program designed to train effective advocates for PWS policy issues.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2015-01-01
Description

Provides advocacy training curriculum for PWSA | USA's special education advocacy programs. Jennifer Bolander completed COPAA's rigorous 9-month advocacy training.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2013-01-01
Description

William & Mary Law School's Institute on Special Education Advocacy provides training for PWSA | USA's Wyatt Special Education Advocacy Training (WSEAT) program. Staff including Evan Farrar and Jennifer Bolander have graduated from this institute.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2001-01-01
Description

Longstanding partnership for systemic disability rights advocacy. Collaborates on major cases involving IDEA, ADA, and Section 504 affecting students with disabilities including PWS.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2001-01-01
Description

Network of federally-mandated disability advocacy organizations partnered to address systemic issues affecting people with PWS and other disabilities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2001-01-01
Description

Partnership providing access to legal services for low-income individuals with disabilities, supporting PWSA | USA's advocacy mission.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

IPWSO is the global umbrella for national PWS associations, providing scientific and medical support, advocacy resources, and an international conference network. It co-hosted the 2025 United in Hope Conference with PWSA | USA and FPWR, making it a direct peer in mission and family-support services.

TypeDirect peer
Description

Rett Syndrome Research Trust is a US-focused rare-disease nonprofit combining family support, advocacy, and aggressive research funding for a single-gene neurodevelopmental disorder. It mirrors PWSA | USA's mission architecture and corporate sponsorship model for a similarly sized rare disease community.

TypeBroad incumbent
Description

Autism Society of America is a large, established national nonprofit serving the autism community with advocacy, education, and support services. It is comparable as a broader neurodevelopmental advocacy peer, though it serves a much larger and more heterogeneous population than PWSA | USA.

TypeDirect peer
Description

The Angelman Syndrome Foundation is a US-based nonprofit providing family support, advocacy, and research funding for another rare neurodevelopmental disorder with overlapping genetic and behavioral challenges. It is comparable in structure (chapter network, family support, pharma partnerships, patient registry) and donor demographic to PWSA | USA.

TypeBroad incumbent
Description

NORD is the US umbrella advocacy organization for all rare diseases, of which PWSA | USA is a Platinum member. It is a broad incumbent providing cross-disease policy advocacy, research grants, and patient assistance programs that overlap with PWSA | USA's federal advocacy and patient support services.

TypeEmerging player
Description

The Phelan-McDermid Syndrome Foundation is a smaller US rare-disease patient advocacy organization supporting families affected by a different rare neurodevelopmental disorder. It is comparable as a peer in mission, family-support programming, and pharma partnership model, though smaller in scale.

TypeEmerging player
Description

Pitt Hopkins Research Foundation is a small US rare-disease nonprofit funding research and supporting families affected by Pitt-Hopkins syndrome, a rare neurodevelopmental disorder. Comparable to PWSA | USA in mission, family support structure, and reliance on a tight community of affected families for fundraising.

TypeDirect peer
Description

FPWR is the other primary US-based PWS nonprofit, focused specifically on funding research to eliminate the challenges of Prader-Willi Syndrome. It is the most direct peer—co-hosting PWSA | USA's international conference and competing for the same donor and pharma dollars across an overlapping family constituency.

TypeBroad incumbent
Description

EveryLife Foundation is a US rare-disease policy and advocacy organization working across all rare diseases on federal legislative and regulatory issues. Comparable to PWSA | USA's federal advocacy function (e.g., D.C. Fly-In) but operating as a cross-disease incumbent rather than a single-disease specialist.

TypeDirect peer
Description

FRAXA Research Foundation funds research and provides family/community support for Fragile X syndrome, another rare neurodevelopmental genetic disorder. It is directly comparable to PWSA | USA in target constituency, advocacy footprint, and reliance on corporate sponsorship from pharma active in CNS drug development.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Prader‐Willi Syndrome Association | USA

Rare Disease Patient Advocacypwsausa.org

Prader-Willi Syndrome Association | USA is a 501(c)(3) nonprofit founded in 1975 that provides 24/7 crisis support, family services, educational advocacy, professional training, and research coordination for individuals with Prader-Willi Syndrome and their families across the United States.

What Prader‐Willi Syndrome Association | USA does

PWSA | USA is a 501(c)(3) nonprofit patient advocacy organization founded in 1975 and headquartered in Brandon, Florida, dedicated to supporting individuals affected by Prader-Willi Syndrome and their families. The organization operates as the de facto U.S. national advocacy body for PWS, a rare genetic condition affecting approximately 1 in 15,000 births. Its service portfolio spans direct family support (24/7 crisis line, parent mentoring, grief counseling, Package of Hope for newly diagnosed families), educational advocacy (WSEAT program, School Success Toolkit, IEP consulting), professional training (ECHO 4 PWS telementoring, Residential Providers Conference), and research coordination (Global PWS Registry, clinical trials information, brain tissue donation program, PWS Connect research initiative). Content and community channels include the PWS United podcast, segmented Facebook support groups by life stage and family role, the annual United in Hope National Convention, regional roadshows, and a biennial D.C. Fly-In advocacy event.

PWSA | USA generates revenue through individual donations, a tiered corporate sponsorship program (Diamond $300K, Platinum $200K, Gold $100K, Silver $50K) targeted at rare-disease pharmaceutical companies, planned giving and bequests, donor-advised funds, employer matching gifts, and a portfolio of fundraising events. Its go-to-market approach is community-led and event-driven, anchored by the annual national convention and supported by a national chapter network. The organization has no proprietary technology products; community platforms are built on third-party infrastructure (Trend Community for PWS Connect, Podbean for the podcast). Recent strategic activity includes the first joint International PWS Conference co-hosted with FPWR and IPWSO in June 2025, alignment with Soleno Therapeutics and subsequently Neurocrine Biosciences around the March 2025 FDA approval of VYKAT XR, and the 50th-anniversary Journey of Hope Gala in 2025.

Key leadership comprises CEO Stacy Ward, MS, BCBA, and founder Fausta Deterling. The organization is governed by a Board of Directors with input from a Special Education Advisory Board, CSAB Advisory Board, and Adults with PWS Advisory Board. Notable community advisors include Dr. Amy McTighe of Children's Institute of Pittsburgh. No parent company or private equity ownership exists; the organization operates autonomously as a 501(c)(3) public charity (Tax ID 41-1306908).

Prader‐Willi Syndrome Association | USA firmographics

Firmographics
Name
Prader‐Willi Syndrome Association | USA
Legal name
Prader-Willi Syndrome Association | USA
Website
https://pwsausa.org
Company type
Private
Founded year
1975
Operating status
Operating
Short description
Prader-Willi Syndrome Association | USA is a 501(c)(3) nonprofit founded in 1975 that provides 24/7 crisis support, family services, educational advocacy, professional training, and research coordination for individuals with Prader-Willi Syndrome and their families across the United States.
Ownership category
akta.pro rank

Where Prader‐Willi Syndrome Association | USA is headquartered

Location

Headquarters

HQ city
Brandon
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Prader‐Willi Syndrome Association | USA business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Individual Donations: One-time and recurring donations from individuals, families, and supporters of the PWS community. Donations can be made online, by mail, or through social media platforms including Facebook fundraisers.
  2. Corporate Sponsorship: Tiered corporate sponsorship program with Diamond ($300,000), Platinum ($200,000), Gold ($100,000), Silver ($50,000) levels. Includes sponsor benefits for events, programs, and visibility.
  3. Planned Giving and Bequests: Legacy and planned giving programs including bequests, endowment funds, and tribute gifts. The organization offers sample bequest language for donors including unconditional, contingent, residue, and specific purpose bequests.
  4. Donor Advised Funds: Accepts grants from Donor Advised Funds (DAFs) as a distribution method for charitable giving.
  5. Fundraising Events: Various fundraising events including Move for PWS, Dancing Through the Decades, Cocktails for a Cause, Hummus & Watermelon brunches, golf tournaments, and seasonal campaigns.
  6. Matching Gifts: Corporate matching gift program where employers match employee donations, doubling the impact of individual contributions.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractDiamond Corporate Sponsor - $300,000
OtherMulti-year contractPlatinum Corporate Sponsor - $200,000
OtherMulti-year contractGold Corporate Sponsor - $100,000
OtherMulti-year contractSilver Corporate Sponsor - $50,000

Go-to-market motion3 records

Distribution channels6 records

Marketing channels11 records

Prader‐Willi Syndrome Association | USA product offering

Product offering

Core offering

PWSA | USA is a 501(c)(3) nonprofit organization that delivers a comprehensive suite of support, education, advocacy, and research services for individuals affected by Prader-Willi Syndrome (PWS) and their families. Core offerings include a 24-hour crisis phone line, the Package of Hope for newly diagnosed families, parent mentoring, grief support, special education advocacy (WSEAT), the ECHO 4 PWS telementoring program, regional roadshows, the annual United in Hope National PWS Convention, the Global PWS Registry, and the PWS Connect Community & Research Initiative.

Product overview

PWSA | USA offers a comprehensive suite of support services, educational resources, advocacy programs, and research initiatives for individuals and families affected by Prader-Willi Syndrome. The organization provides a 24-hour crisis support line, parent mentoring, grief support, and the Package of Hope for newly diagnosed families. Key programs include the ECHO 4 PWS healthcare education initiative, the annual United in Hope National Convention, the Residential Providers Conference, and the PWS Connect Community & Research Initiative. The organization also maintains educational resources including the Growth Hormone Booklet, PWS Fact Sheets, and the PWS United Podcast. Advocacy programs include the biennial D.C. Fly-In and the PWS Advocacy Master Class. Research support is provided through the Global PWS Registry, clinical trials information, and brain tissue donation program.

Differentiator

Problem solved

Functional benefit

Products and services

  • 24-Hour Crisis Phone Line 24/7/365 crisis support line staffed by knowledgeable Family Support team members providing immediate expert support to families facing medical or behavioral emergencies.
  • Package of Hope Comprehensive support package provided to newly diagnosed families containing educational literature, counseling resources, nutrition and medical information about Prader-Willi Syndrome.
  • Family Support Services Comprehensive support services for individuals diagnosed with PWS, their families, and care providers, providing critical information and resources on PWS care, crisis counseling, and referrals.
  • Parent Mentoring Program Program connecting veteran PWS parents with newly diagnosed families to provide support, referrals to physicians, best practices, and additional support benefits.
  • Grief Support Services Grief counseling and emotional support services for members of the PWS community who are grieving.
  • ECHO 4 PWS Project ECHO-based telemedicine and education program designed to increase access to locally trained specialists and decrease healthcare disparity through rapid dissemination of best practices for PWS care.
  • United in Hope National PWS Convention Annual national convention bringing together individuals with PWS, families, and professionals for education, networking, and community connection.
  • Residential Providers Conference Annual conference for residential care providers serving individuals with Prader-Willi syndrome, offering training, best practices sharing, and networking opportunities.
  • D.C. Fly-In Advocacy Event Biennial advocacy event bringing PWS advocates to Washington D.C. to meet with elected officials and advance legislative priorities.
  • PWS Advocacy Master Class Six-week program designed in collaboration with Patients Rising providing a robust curriculum for becoming an effective PWS policy advocate.
  • School Success Program Program helping parents navigate educational systems, advocate for their child's rights and accommodations, and create effective learning environments for students with PWS.
  • Provider Trainings Training programs for healthcare providers, residential staff, and caregivers serving individuals with PWS.
  • PWS Connect Community & Research Initiative

Quantifiable outcome

  • 24/7 crisis support available 365 days per year
  • +2 more outcomes

Companies that use Prader‐Willi Syndrome Association | USA

Customer profile

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Prader‐Willi Syndrome Association | USA technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Prader‐Willi Syndrome Association | USA partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered minor, flagship and core.

  • Neurocrine BiosciencesminorStrategic or Co-development Partner · 6 April 2026Community update partner following acquisition of Soleno Therapeutics on April 6, 2026. Soleno developed VYKAT XR (diazoxide choline controlled-release), the first FDA-approved treatment for hyperphagia in PWS.
  • Foundation for Prader-Willi Research (FPWR)flagshipStrategic or Co-development Partner · 24 June 2025Co-host of the United in Hope International PWS Conference held June 24-28, 2025 at Arizona Grand Resort and Spa in Phoenix. First joint conference bringing together all three major PWS organizations for the largest international PWS conference ever held.
  • International Prader-Willi Syndrome Organisation (IPWSO)flagshipStrategic or Co-development Partner · 24 June 2025Co-host of the United in Hope International PWS Conference, partnering with PWSA | USA and FPWR to create the first joint international PWS conference, bringing together families, researchers, and professionals from around the world.
  • Soleno TherapeuticscoreStrategic or Co-development Partner · 26 March 2025Longstanding community partner whose VYKAT XR treatment received FDA approval on March 26, 2025 - a historic milestone for the PWS community. PWSA | USA provides community updates and support for patients accessing this treatment.
  • ECHO 4 PWS ProgramcoreStrategic or Co-development Partner · 1 January 2023Project ECHO program launched in May 2023 to increase access to specialized PWS care by training local providers. Uses telementoring to disseminate best practices to healthcare providers lacking PWS expertise.
  • National Organization for Rare Disorders (NORD)coreOthers · 1 January 2021Platinum member of NORD, the leading rare disease advocacy organization in the United States. Provides access to resources, advocacy coordination, and peer support among rare disease organizations.
  • Autism BrainNetcoreStrategic or Co-development Partner · 1 January 2021Partner organization supporting brain tissue donation for research. Helps facilitate post-mortem brain tissue donation from individuals with PWS to advance understanding of the condition.
  • Aardvark TherapeuticsminorStrategic or Co-development Partner · 1 January 2021Community update partner working on the HERO clinical trial for PWS treatment. PWSA | USA shares updates with the community about clinical trial developments and pauses.
  • Children's Institute of PittsburghminorStrategic or Co-development Partner · 1 January 2021Home to the Center for Prader-Willi Syndrome and PWS Program Manager Dr. Amy McTighe, who serves as Chair of PWSA | USA's Special Education Advisory Board.
  • Prader-Willi Syndrome Association of ColoradominorStrategic or Co-development Partner · 1 January 2021State chapter providing IEP consulting services and collaborating with the PWS multi-disciplinary clinic at Children's Hospital in Denver.
  • Patients RisingminorStrategic or Co-development Partner · 1 January 2021Collaboration to develop the PWS Advocacy Master Class - a six-week program designed to train effective advocates for PWS policy issues.
  • Council of Parent Advocates and Attorneys (COPAA)coreStrategic or Co-development Partner · 1 January 2015Provides advocacy training curriculum for PWSA | USA's special education advocacy programs. Jennifer Bolander completed COPAA's rigorous 9-month advocacy training.
  • William & Mary Law SchoolcoreStrategic or Co-development Partner · 1 January 2013William & Mary Law School's Institute on Special Education Advocacy provides training for PWSA | USA's Wyatt Special Education Advocacy Training (WSEAT) program. Staff including Evan Farrar and Jennifer Bolander have graduated from this institute.
  • Southern Poverty Law CentercoreStrategic or Co-development Partner · 1 January 2001Longstanding partnership for systemic disability rights advocacy. Collaborates on major cases involving IDEA, ADA, and Section 504 affecting students with disabilities including PWS.
  • Protection and Advocacy (P&A) ProgramscoreStrategic or Co-development Partner · 1 January 2001Network of federally-mandated disability advocacy organizations partnered to address systemic issues affecting people with PWS and other disabilities.
  • Legal Services Corporation (LSC)coreStrategic or Co-development Partner · 1 January 2001Partnership providing access to legal services for low-income individuals with disabilities, supporting PWSA | USA's advocacy mission.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Prader‐Willi Syndrome Association | USA competitors and assessment

Company assessment

Direct peers

  • International Prader-Willi Syndrome Organisation (IPWSO): IPWSO is the global umbrella for national PWS associations, providing scientific and medical support, advocacy resources, and an international conference network. It co-hosted the 2025 United in Hope Conference with PWSA | USA and FPWR, making it a direct peer in mission and family-support services.
  • Rett Syndrome Research Trust: Rett Syndrome Research Trust is a US-focused rare-disease nonprofit combining family support, advocacy, and aggressive research funding for a single-gene neurodevelopmental disorder. It mirrors PWSA | USA's mission architecture and corporate sponsorship model for a similarly sized rare disease community.
  • Angelman Syndrome Foundation: The Angelman Syndrome Foundation is a US-based nonprofit providing family support, advocacy, and research funding for another rare neurodevelopmental disorder with overlapping genetic and behavioral challenges. It is comparable in structure (chapter network, family support, pharma partnerships, patient registry) and donor demographic to PWSA | USA.
  • Foundation for Prader-Willi Research (FPWR): FPWR is the other primary US-based PWS nonprofit, focused specifically on funding research to eliminate the challenges of Prader-Willi Syndrome. It is the most direct peer—co-hosting PWSA | USA's international conference and competing for the same donor and pharma dollars across an overlapping family constituency.
  • FRAXA Research Foundation: FRAXA Research Foundation funds research and provides family/community support for Fragile X syndrome, another rare neurodevelopmental genetic disorder. It is directly comparable to PWSA | USA in target constituency, advocacy footprint, and reliance on corporate sponsorship from pharma active in CNS drug development.

Broad incumbents

  • Autism Society of America: Autism Society of America is a large, established national nonprofit serving the autism community with advocacy, education, and support services. It is comparable as a broader neurodevelopmental advocacy peer, though it serves a much larger and more heterogeneous population than PWSA | USA.
  • National Organization for Rare Disorders (NORD): NORD is the US umbrella advocacy organization for all rare diseases, of which PWSA | USA is a Platinum member. It is a broad incumbent providing cross-disease policy advocacy, research grants, and patient assistance programs that overlap with PWSA | USA's federal advocacy and patient support services.
  • EveryLife Foundation for Rare Diseases: EveryLife Foundation is a US rare-disease policy and advocacy organization working across all rare diseases on federal legislative and regulatory issues. Comparable to PWSA | USA's federal advocacy function (e.g., D.C. Fly-In) but operating as a cross-disease incumbent rather than a single-disease specialist.

Emerging players

  • Phelan-McDermid Syndrome Foundation: The Phelan-McDermid Syndrome Foundation is a smaller US rare-disease patient advocacy organization supporting families affected by a different rare neurodevelopmental disorder. It is comparable as a peer in mission, family-support programming, and pharma partnership model, though smaller in scale.
  • Pitt Hopkins Research Foundation: Pitt Hopkins Research Foundation is a small US rare-disease nonprofit funding research and supporting families affected by Pitt-Hopkins syndrome, a rare neurodevelopmental disorder. Comparable to PWSA | USA in mission, family support structure, and reliance on a tight community of affected families for fundraising.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Prader‐Willi Syndrome Association | USA social profiles

Digital presence

Prader‐Willi Syndrome Association | USA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Prader‐Willi Syndrome Association | USA leadership team

Management profile

Number of profiles

Profiles4 records

Prader‐Willi Syndrome Association | USA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Prader‐Willi Syndrome Association | USA M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prader‐Willi Syndrome Association | USA

What does Prader‐Willi Syndrome Association | USA do?

PWSA | USA is a 501(c)(3) nonprofit organization that delivers a comprehensive suite of support, education, advocacy, and research services for individuals affected by Prader-Willi Syndrome (PWS) and their families. Core offerings include a 24-hour crisis phone line, the Package of Hope for newly diagnosed families, parent mentoring, grief support, special education advocacy (WSEAT), the ECHO 4 PWS telementoring program, regional roadshows, the annual United in Hope National PWS Convention, the Global PWS Registry, and the PWS Connect Community & Research Initiative.

Is Prader‐Willi Syndrome Association | USA a public or private company?

Prader‐Willi Syndrome Association | USA is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Prader‐Willi Syndrome Association | USA founded?

Prader‐Willi Syndrome Association | USA was founded in 1975.

Where is Prader‐Willi Syndrome Association | USA based?

Prader‐Willi Syndrome Association | USA is headquartered in Brandon, United States, in the North America region.

How does Prader‐Willi Syndrome Association | USA make money?

Six revenue lines are on record. Individual Donations are the primary driver. The others are corporate Sponsorship, planned Giving and Bequests, donor Advised Funds, fundraising Events and matching Gifts.

Who are Prader‐Willi Syndrome Association | USA's main competitors?

Direct peers on record are International Prader-Willi Syndrome Organisation (IPWSO), Rett Syndrome Research Trust, Angelman Syndrome Foundation, Foundation for Prader-Willi Research (FPWR) and FRAXA Research Foundation. Broad incumbents are Autism Society of America, National Organization for Rare Disorders (NORD) and EveryLife Foundation for Rare Diseases. Emerging players are Phelan-McDermid Syndrome Foundation and Pitt Hopkins Research Foundation.

Does Prader‐Willi Syndrome Association | USA have an API?

No public API is recorded for Prader‐Willi Syndrome Association | USA.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PraderwillinewsThere’s no autopilot when raising 2 kids with Prader-Willi syndromeA parent describes the intense, non-stop logistical and cognitive labor required to care for two children with Prader-Willi syndrome, highlighting the constant tracking of medical appointments, dietary restrictions, and treatments. The article emphasizes that unlike typical parenting which can become automated, managing this condition demands continuous mental engagement from both caregivers to prevent errors and ensure proper care.The BulletinFamilies who suffer from rare genetic disorder find community in RedmondFour families affected by Prader-Willi Syndrome gathered in Redmond, Oregon on Saturday for the first community-building event organized by the Prader-Willi Syndrome Association (PWSA) in Central Oregon, allowing participants who previously had to travel to Seattle or Arizona to meet others with the same rare genetic disorder. The event, part of PWSA's Pacific Northwest roadshow, also connected families with healthcare resources including Shriners Children's Hospital and introduced Vykat XR, the first medication specifically approved for hyperphagia associated with the syndrome. Prader-Willi Syndrome is a genetic disorder affecting between 350,000 to 400,000 people worldwide, caused by an abnormality on the 15th chromosome.GlobeNewswireAardvark Therapeutics to Present Data on Pipeline Programs at Upcoming ObesityWeekAardvark Therapeutics announced it will present poster data on its pipeline programs ARD-101, ARD-201, and WE-868 at ObesityWeek 2025, being held November 4-7, 2025 in Atlanta, Georgia. The presentations will feature data on its gut-restricted bitter taste receptor agonist ARD-101 for Prader-Willi Syndrome, its fixed-dose combination ARD-201 for GLP-1 therapy complement, and its preclinical mitochondrial metabolism modulator WE-868 for obesity and diabetes. The company will also host an investor webinar on November 5, 2025 featuring key opinion leaders and representatives from the Prader-Willi Syndrome Association - USA to discuss the presented data.PR NewswireHARMONY BIOSCIENCES SHOWCASES THE NEWEST PATIENTS AT THE HEART AND PROGRESS AT THE HEART AWARD RECIPIENTSHarmony Biosciences has announced the latest recipients of its Patients at the Heart and Progress at the Heart award programs, which provide funding to nonprofit organizations addressing sleep disorders and rare neurological diseases. The newest awardees include Kleine-Levin Syndrome Foundation, Prader-Willi Syndrome Association | USA, Rare & Black, and Geisinger Health Foundation, with the programs collectively having supported 39 initiatives over four years. The awards support initiatives addressing comprehensive needs of affected individuals and communities as well as disparities in rare neurological disease and sleep disorder care.